Contact this trialFirst, we need to learn more about you.
Chemotherapy
Chemotherapy + SBRT for Pancreatic Cancer
Recruiting1 awardPhase 2
New Haven, Connecticut
This trial will compare a new chemotherapy treatment for pancreatic cancer to standard care. The new treatment consists of modified FOLFIRINOX followed by SBRT. The primary hypothesis is that the new treatment will improve progression free survival.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.